Navigation Links
ReNu MultiPlus Multi-Purpose Solution

ProductsReNu MultiPlus Multi-Purpose Solution
Company Bausch & Lomb Storz
Item ReNu MultiPlus Multi-Purpose Solution
Features Lens care has been made easier. Outstanding disinfecting with powerful cleaning and protein removal, no special vials, no extra steps, no hassles. Safe lens storage for up to 30 days.
Description Renu Multiplus no rub formula is the most convenient multi-purpose no rub regimen available today. All steps in one bottle without the need to rub: cleans, rinses, disinfects, stores your soft contact lenses and removes protein build-up when used daily. Its the only multi-purpose solution that contains Hydranate, a special ingredient that removes protein deposits while you clean your lenses. Renu Multiplus no rub formula makes lens care easy.
Info Bausch & Lomb Storz
Customer Service: (585) 338-6000
Web site: http://www.storz.com/

Related medicine products :

1. Renu MultiPlus Multi-Purpose Solution No Rub Formula
2. Renu Multi-Purpose Solution
3. Opti-One Multi-Purpose Solution
4. Renu Multiplus Multi-Purpose Solution No Rub Formula
5. Multi-Purpose Stand Magnifier
6. Mendez Multi-Purpose LASIK Forceps.
7. Mendez Multi-Purpose LASIK Forceps
8. The Multi-Purpose Medical-Surgical Shoe
9. Amsco® Auto Lift Multi-Purpose Stirrups
10. Solo-Care Brand Multipurpose Solution
11. Sensitive Eyes Plus Saline Solution
Measure SpO2 and tcpCO2 with a single sensor.
The TCM400 is the first and only portable instrument to provide up to six simultaneous measurements of transcutaneous oxygen tension (tcpO2)
Two separate sensors provide continuous measurement of tcpO2/tcpCO2 and SpO2.
...versity is the only online source of nationally ac...sts, critical care nurses and other healthcare pro...re available online 24/7, so you can take them at ... and a certificate is issued upon course completio...
Medicine Products:
(Date:12/2/2008)...swire/ -- Today, the University HealthSystem,Cons... has been appointed Vice,President, Quality and P...ing,a year and a half as director of quality and ...al in Chicago, Ill. Previously, she was the senio...area. , "Julie,s experience at Northwestern...
(Date:12/2/2008)...ec. 1 diaDexus, Inc. today,announ...mated format of the,PLAC Test for Lp-PLA2. This a...unning on a wide range of clinical chemistry analy...g Administration (FDA) in December 2007. diaDexus ...d PLAC Test to Europe. , The PLAC Test is t...
(Date:12/2/2008)...onash University, The Brigham and Women,s Hospital...ceuticals has found a new drug with the potential ... shift work. , Dr Shantha Rajaratnam from Monas...d Psychological Medicine said tasimelteon, a drug ...uld be a highly effective treatment for circadian ...
(Date:12/2/2008)...for an Injunction in Federal Court to Reclaim Over...ewswire-USNewswire/ -- Registered nurses for River...al Medical Center, filed a Fair Labor Standards Ac...day to stop the county from violating federal law ...ho are seeking to represent all 867 registered nur...
Breaking Medicine News(10 mins):Health News:Julie Cerese Returns to University HealthSystem Consortium as Vice President of Quality and Patient Safety 2Health News:diaDexus Receives CE Mark Certification for the PLAC(R) Test 2Health News:New medication brings hope of jet lag cure 2Health News:Riverside County Registered Nurses File a Lawsuit to Stop County's Violation of Federal Law 2
... beats per minute (BPM). If the rhythm of the hear...rave danger. This was the case for Jeffrey Nauser....er repeat trips to the Emergency Room where his li...frey’s story began four years ago while on a job i...
...ouch to recover before returning to sports, but an...east not yet. // One Ohio State University Medical...hanical support devices for the heart will be put ...heart to rest and recover itself. Right now, such ...
...nd patients about commonly used thyroid medication...of the drugs, a senior endocrinologist has warned.... University and The Alfred and Epworth Hospitals i...ion (PI) for thyroid medications published in phar...
...search project, titled 'Sun Safe in the Middle Sch...January issue of "Pediatrics”, was undertaken to s...the risks of skin cancer. //The importance of usin...he risk of skin cancer was the keynote of the proj...
Other Medicine News:Health News:Rewiring the Heart 2Health News:Pumps Someday May Allow Patients to Recover Their Own Hearts 2Health News:Pumps Someday May Allow Patients to Recover Their Own Hearts 3Health News:Medicine Information Out of Date 2
(Date:12/1/2008)...OLIS, Dec. 1 Roche announced today...ifferences in perceived pain and,discomfort assoc...blood,glucose monitoring systems and lancing devi...dicated that, overall, the ACCU-CHEK Aviva and ACC...ems and the ACCU-CHEK Multiclix, ACCU-CHEK,Softcl...
(Date:12/1/2008)... MEETING, Pa., Dec. 1 G...ed that dosing of subjects has begun in study MSI-... Phase 1b study of trodusquemine (MSI-1436) in ove...novel therapeutic for the treatment of type 2 diab...rally to regulate insulin and leptin pathways thro...
(Date:12/1/2008)...O, Dec. 1 Vical Incorpor... of a $1.0 million milestone payment from Merck &a...of a Phase I clinical trial of an investigational ...accine is based on Vical,s DNA gene delivery techn...iptase (hTERT). hTERT is the subject of separate l...
(Date:11/28/2008)...OLIS, Nov. 28 Eli Lilly ...lemental New Drug Application (sNDA) from,the U.S...R) (duloxetine HCl),for the management of chronic...,the first half of 2009, adding data from a recent...itis pain of the knee. , The decision does ...
Breaking Medicine Technology:Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Worker ants of the world unite 21 You have nothing to lose but your fertility 5939 1Worker ants of the world unite 21 You have nothing to lose but your fertility 5939 2HMS Presents 4th Annual Heroes of Healthcare Awards 30142 1HMS Presents 4th Annual Heroes of Healthcare Awards 30142 2HMS Presents 4th Annual Heroes of Healthcare Awards 30142 3Compound Tied to Cognitive Deficits in Schizophrenia 30140 1Compound Tied to Cognitive Deficits in Schizophrenia 30140 2Care Improvement Plus Achieves Top Scores for First SNP Evaluation Measures 30137 1Care Improvement Plus Achieves Top Scores for First SNP Evaluation Measures 30137 2